Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Thermo Fisher Scientific Inc. (NYSE: TMO) was $556.52 for the day, down -1.67% from the previous closing price of $565.95. In other words, the price has decreased by -$1.67 from its previous closing price. On the day, 1.94 million shares were traded. TMO stock price reached its highest trading level at $568.34 during the session, while it also had its lowest trading level at $556.19.
Ratios:
Our analysis of TMO’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.33 and its Current Ratio is at 1.70. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.68.
Barclays Downgraded its Overweight to Equal Weight on January 24, 2024, whereas the target price for the stock was revised from $475 to $555.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 04 ’24 when CASPER MARC N sold 10,000 shares for $570.16 per share. The transaction valued at 5,701,590 led to the insider holds 123,816 shares of the business.
CASPER MARC N sold 10,000 shares of TMO for $5,672,768 on Jun 03 ’24. The Chairman & CEO now owns 123,816 shares after completing the transaction at $567.28 per share. On May 14 ’24, another insider, Lagarde Michel, who serves as the Executive Vice President & COO of the company, sold 20,000 shares for $590.05 each. As a result, the insider received 11,801,000 and left with 18,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 212432601088 and an Enterprise Value of 240953769984. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.70, and their Forward P/E ratio for the next fiscal year is 22.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.00 while its Price-to-Book (P/B) ratio in mrq is 4.67. Its current Enterprise Value per Revenue stands at 5.671 whereas that against EBITDA is 22.356.
Stock Price History:
Over the past 52 weeks, TMO has reached a high of $603.82, while it has fallen to a 52-week low of $415.60. The 50-Day Moving Average of the stock is -2.98%, while the 200-Day Moving Average is calculated to be 3.77%.
Shares Statistics:
TMO traded an average of 1.41M shares per day over the past three months and 1801050 shares per day over the past ten days. A total of 386.65M shares are outstanding, with a floating share count of 381.00M. Insiders hold about 0.19% of the company’s shares, while institutions hold 90.19% stake in the company. Shares short for TMO as of 1715731200 were 2800765 with a Short Ratio of 2.31, compared to 1713139200 on 2587236. Therefore, it implies a Short% of Shares Outstanding of 2800765 and a Short% of Float of 0.73.
Dividends & Splits
With its trailing 12-month dividend rate of 1.44, TMO has a forward annual dividend rate of 1.48. Against a Trailing Annual Dividend Yield of 0.0025443945The stock’s 5-year Average Dividend Yield is 0.22.
Earnings Estimates
As of right now, 21.0 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $5.12 for the current quarter, with a high estimate of $5.2 and a low estimate of $5.07, while EPS last year was $5.15. The consensus estimate for the next quarter is $5.45, with high estimates of $5.69 and low estimates of $5.28.
Analysts are recommending an EPS of between $22.06 and $21.45 for the fiscal current year, implying an average EPS of $21.73. EPS for the following year is $24.33, with 26.0 analysts recommending between $25.56 and $22.28.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 19 analysts. It ranges from a high estimate of $10.62B to a low estimate of $10.38B. As of the current estimate, Thermo Fisher Scientific Inc.’s year-ago sales were $10.98BFor the next quarter, 19 analysts are estimating revenue of $10.72B. There is a high estimate of $10.94B for the next quarter, whereas the lowest estimate is $10.37B.
A total of 25 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $43.83B, while the lowest revenue estimate was $42.34B, resulting in an average revenue estimate of $42.99B. In the same quarter a year ago, actual revenue was $42.86BBased on 25 analysts’ estimates, the company’s revenue will be $46.09B in the next fiscal year. The high estimate is $46.8B and the low estimate is $45.23B.
